The Food and Drug Administration today released for comment clarifying what types of clinical and patient decision support software would no longer be regulated by the agency as a medical device under the 21st Century Cures Act. FDA Commissioner Scott Gottlieb, M.D., the guidance generally excludes from regulation software that allows a health care provider or patient to independently review the basis for its treatment recommendations. In addition, FDA released clarifying that certain digital health technologies, such as mobile apps intended solely to maintain or encourage a healthy lifestyle, generally fall outside the scope of FDA regulation under the Act, and adopting international principles for harmonizing the regulation of software with a medical purpose.

Related News Articles

Headline
The AHA June 16 responded to a request for information on the health technology ecosystem from the Centers for Medicare & Medicaid Services and Assistant鈥�
Headline
The Centers for Medicare & Medicaid Services and the Assistant Secretary for Technology Policy/Office of the National Coordinator for Health Information鈥�
Headline
The Department of Health and Human Services Dec. 16 published a final rule implementing certain provisions related to information blocking exceptions. The rule鈥�
Headline
The Department of Health and Human Services Sept. 17 announced it has awarded a total of $2 million to two recipients to create tools to improve care delivery鈥�
Headline
The Department of Health and Human Services July 10 released a proposed rule designed to improve health information sharing and interoperability. The Health鈥�
Headline
The Department of Health and Human Services鈥� Office of the National Coordinator for Health Information Technology March 27 released for comment through May 28鈥�